Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Rbc Bioscience Corp
Rbc Bioscience Corp
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Rbc Bioscience Corp
Stock Price
NT$19.9
2024-10-29
Market Capitalization
NT$259.5 M
2024-10-29
Revenue
NT$219.7 M
FY, 2025
Rbc Bioscience Corp Summary
Company Summary
Overview
RBC Bioscience is a manufacturer and seller of reagents and devices for life science and molecular diagnosis. It offers real genomics, DNA fragments, plasmids, purification enzymes, nucleic acid extractors, and other products.
Type
Public
Status
Active
Founded
2003
Website
http://rbcbioscience.com
Cybersecurity rating
Sectors
Manufacturing & Industrial
distribution
medical devices
Homepage
Linkedin
youtube
twitter
Table of Contents
Financials
Competitors
Rbc Bioscience Corp Financials
Summary Financials
Revenue (FY, 2025)
NT$219.7M
Gross profit (FY, 2025)
NT$109.2M
Net income (FY, 2025)
NT$23.5M
Cash (FY, 2025)
NT$36.4M
EBIT (FY, 2025)
NT$39.2M
Enterprise value
$630.6M
Competitors and Similar Companies
Yuwell Group
Manufacturing & Industrial - Public
Kembla
Manufacturing & Industrial - Private
Viamed
Manufacturing & Industrial - Private
Sud-Laborbedarf
Manufacturing & Industrial - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top